|Products||Vidiera NsP Nucleic Acid Sample Preparation Platform|
|Company||Beckman Coulter, Inc.|
|Item||Vidiera NsP Nucleic Acid Sample Preparation Platform|
|Description|| The Vidiera NsP Nucleic Sample Preparation Platform provides flexible, automated extraction and downstream reaction setup. The platform can prepare up to 96 patient samples from primary tubes in just two and one half-hours, and performs onboard quantitation and normalization and PCR reaction setup in 30 minutes each. Based on Beckman Coulters proprietary primary tube handling technology and proven Biomek automation, this platform can replace several instruments, enabling labs to centralize pre-analytical functions in one room.
Vidiera NsPs versatility allows the use of a variety of primary tube sizes and the platform can output to a wide range of labware formats. The systems software provides flexible results reporting types and security levels. Predefined, editable protocols automate extraction, quantitation, normalization and reaction set-ups, while user-defined protocols accommodate home-brew extraction applications.
Through an agreement with QIAGEN GmbH, Beckman Coulter will offer custom QIAamp** extraction reagents for the reliable and efficient purification of viral nucleic acids from serum and plasma samples, as well as genomic DNA from blood samples. Beckman Coulter has validated these chemistries, along with specific labware, for use on the Vidiera NsP to offer customers a total solution.
The Vidiera NsP platform and reagents are ideal for both virology and pathology applications and can be integrated with Beckman Coulters new Vidiera NsD Nucleic Sample Detection System. The platform is currently available only in the United States and will be marketed to laboratories identified as high-complexity under the CLIA regulations.
|Info|| Beckman Coulter, Inc.|
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com